Tazarotene 00713-0805
Product NDC
00713-0805- Manufacturer
- Cosette Pharmaceuticals, Inc.
- Dosage Form
- Gel
- Route
- Topical
- Product Type
- Human Prescription Drug
- Marketing Start
- September 14, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215433
Need to source Tazarotene? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tazarotene | .5 mg/g |
Drug Class
Retinoid [EPC]Retinoid [EPC]Retinoids [CS]
Packaging Options(2)
1 TUBE in 1 CARTON (0713-0805-31) / 30 g in 1 TUBE
1 TUBE in 1 CARTON (0713-0805-99) / 100 g in 1 TUBE